Regeneron Reports Third Quarter 2016 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. CHRW
9. AMD
10. RXO

Go back to Regeneron Reports Third Quarter 2016 Financial and Operating Results

Regeneron Pharma (REGN) PT Cut at Baird on 'Uneventful Earnings'

November 4, 2016 12:40 PM EDT

Baird analyst Brian Skorney lowered his price target on Neutral-rated Regeneron Pharma (NASDAQ: REGN) to $379.00 (from $448.00) following "uneventful earnings."

Skorney commented, "Though earnings were relatively uneventful and the company pulled out an EPS beat on lower operating expenses, Eylea growth continues to... More

Regeneron (REGN) Tops Q3 EPS by 40c; EYLEA Sales Rose 16%

November 4, 2016 6:31 AM EDT

Regeneron (NASDAQ: REGN) reported Q3 EPS of $3.13, $0.40 better than the analyst estimate of $2.73. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.29 billion.

EYLEA sales rose 16% to $854 million, from $734 million in Q315.

2016 Financial... More